Document is current
Any future updates will be listed below
-
Authors
Gotkine, Marc
Caraco, Yoseph
Lerner, Yossef
Blotnick, Simcha
Wanounou, Maor
Slutsky, Shalom Guy
Chebath, Judith
Kuperstein, Graciela
Estrin, Elena
Ben-Hur, Tamir
Hasson, Arik
Molakandov, Kfir
Sonnenfeld, Tehila
Stark, Yafit
Revel, Ariel
Revel, Michel
Izrael, Michal https://orcid.org/0000-0002-2937-9961
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03482050 at ClinicalTrials.govDocuments that mention this clinical trial
Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results
https://doi.org/10.1186/s12967-023-03903-3
-
Funding
Funding for this research was provided by:
Office of the Chief Scientist, Ministry of Economy (77571)
- License Information
-
More Information
Article History
Received: 16 November 2022
Accepted: 18 January 2023
First Online: 14 February 2023
Declarations
:
: The study protocols and informed consent forms were approved by the Israeli Ministry of Health (IMOH), and the institutional review board of Hadassah Medical Center in Jerusalem, Israel. All patients signed informed consent after receiving oral and written information and could withdraw from the study at any time point. The studies were performed in compliance with the World Medical Association Declaration of Helsinki and ICH E6 for Good Clinical Practice.
: Not applicable.
: The authors declare that they have no conflicts of interest.
